Future missions should address the impact of spaceflight on glial clearance pathways, particularly in the presence of proteostressors such as neurodegenerative disease proteins tau, Aβ, huntingtin, or alpha-synuclein. This evidence concerns the gene MAPT and neurodegenerative disease.